Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Scully et al. N Engl J Med 2019; 380: 335–346.
This article was published on January 9, 2019, at NEJM.org.
DOI: 10.1056/NEJMoa1806311
This article was published on January 9, 2019, at NEJM.org.
DOI: 10.1056/NEJMoa1806311
Select your desired language:
English
Italian | Italiano
Spanish | Español
Japanese | 日本
English
Italian | Italiano
Spanish | Español
Japanese | 日本
Content owned, published, and © copyrighted, 2019, by the Massachusetts Medical Society. All rights reserved.
Site provided by Springer Healthcare. Part of the Springer Nature Group.